Curonix Introduces Optimized Peripheral Nerve Stimulation Therapy

Curonix LLC has debuted NervPulse Therapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation (PNS) therapy with the Freedom PNS System. By delivering precise, nerve-specific stimulation, NervPulse Therapy aims to improve clinical results and transform the patient experience.

NervPulse Therapy is built from a clinical foundation of more than 20,000 Freedom PNS procedures* and incorporates long-term data from 13 peer-reviewed publications and over 450 study patients. This extensive real-world and clinical experience has been transformed into an advanced, evidence-based solution developed in collaboration with physicians. By leveraging deep insights, NervPulse Therapy delivers standardized therapy programs for 26 individual peripheral nerves, enabling providers to implement precise therapy. These data-driven programs are designed to optimize device performance, improve procedural efficiency, and maximize patient outcomes by ensuring consistent, reproducible, and long-lasting therapeutic results and benefits.

“At Curonix, we are committed to redefining the boundaries of chronic pain management through innovation and evidence-based solutions,” Curonix CEO Aure Bruneau stated. “NervPulse Therapy is a transformative advancement in peripheral nerve stimulation, leveraging real-world data and clinical excellence to deliver targeted therapy. This approach enhances precision and efficiency for providers but, most importantly, it is intended to elevate the quality of treatment for patients suffering from chronic pain, today. NervPulse Therapy represents a major step forward in our mission to deliver life-changing relief for chronic pain patients.”

Curonix LLC is a Delaware medical technology company developing and commercializing therapies to help relieve chronic pain. The proprietary Freedom PNS System is a non-integrated, minimally-invasive implant that does not include an implanted battery. The Freedom PNS System is powered by HF-EMC (High-Frequency Electromagnetic Coupling) and is comprised of a two-component implantable neurostimulator, an externally worn transmitter, and software used to set patient-specific stimulation programs. The two-component neurostimulator, comprised of an electrode array and a separate surgically connected receiver, is anchored within two separate incisions, including the creation of a subcutaneous pocket. The stimulation program is adjusted as needed to provide pain relief for the patient.